CHICAGO – Illinois and Wisconsin on Monday launched the nation’s first state-sponsored program to help residents buy cheaper prescription drugs from Europe and Canada, despite federal laws banning the practice.
The program, called I-SaveRx, works through a Canada-based clearinghouse and claims it can save residents 25 percent to 50 percent off U.S. retail prices on about 100 prescription medications.
By including pharmacies in Ireland and the United Kingdom, I-SaveRx goes beyond programs in other states that direct residents on how to buy prescription drugs from Canada, where drugs are often cheaper because of government price controls.
The U.S. Food and Drug Administration opposes such reimporting of prescription drugs, saying it cannot guarantee the safety of drugs sold through foreign pharmacies.
“The governor, instead of following established legal avenues to change the law, is instead creating a program that would violate the law by causing the importation of drugs that are themselves illegal,” said William Hubbard, FDA associate commissioner, of Illinois Gov. Rod Blagojevich, who announced on Monday the start of the program.
The FDA has not stopped Minnesota and other states from setting up Internet sites to help consumers buy drugs through Canadian pharmacies. The FDA has sent the pharmaceutical benefits manager that administers the clearinghouse used by I-SaveRx a warning letter about importing drugs to the United States, Hubbard said. But he said the FDA, while sending a letter of complaint to the state of Illinois, will not do anything yet to shut down I-SaveRx.
Illinois, which created the I-SaveRx program, will not import the drugs itself. Instead, it has contracted with a Canadian company to connect residents with 45 foreign pharmacies and wholesalers that have been approved by Illinois health inspectors and verified by Wisconsin.
The clearinghouse will provide information about 100 of the most common brand-name drugs used to treat chronic or long-term conditions.
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.